Results 241 to 250 of about 22,658,601 (368)
Molecular Oncology, EarlyView.EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain +10 more
wiley +1 more source
Correction to 'The 2026 Nucleic Acids Research database issue and the online molecular biology database collection'. [PDF]
Nucleic Acids Reseuropepmc +1 more source
Cancer nanomedicine for therapy: emerging strategies and expanding perspectives. [PDF]
Cancer Biol MedShi L.
europepmc +1 more source
Molecular Oncology, EarlyView.We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu +10 more
wiley +1 more source
Editorial for the Special Issue "Selected Papers from the 3rd International Electronic Conference on Microbiology (ECM 2025)". [PDF]
MicroorganismsJehmlich N.
europepmc +1 more source